Internet and Psychiatry
  • Home
    • Editorials
    • Research news
    • Research papers
    • Interviews with eminent psychiatrists
    • Ten years ago
    • Fifteen years ago
  • Topics
    • Alcohol and Drug Abuse
    • Anxiety Disorders
    • Biomedical Science
    • Compulsive gambling
    • Disaster Medicine
    • Education
    • General Medicine
      • Acupuncture
      • Physical medicine and Rehabilitation
    • Human Rights
    • Interviews with eminent psychiatrists
    • Mood Disorders
      • Bipolar Disorder
      • Depression
      • Seasonal Affective Disorder
    • Neurological Disorders
    • Other Psychiatric Disorders
    • Posttraumatic Stress Disorder
    • Sexual Behavior
  • Books
    • Comorbidity of Depression and Alcohol Use Disorders
    • “Immigration and Mental Health” chapter abstracts
    • “Internet and Suicide” chapter abstracts
    • “Neurobiology of PTSD” chapter abstracts
    • “Suicidal Behavior in Alcohol…” chapter abstracts
    • “Suicide in the Military” chapter abstracts
    • “Terror and Suicide” chapter abstracts
    • “War and Suicide” chapter abstracts
  • Editors
    • Leo Sher, M.D.
    • Alexander Vilens, M.S.
  • Guests
    • Distinguished Guests
    • Our Contributors
  • Reflections
    • Poetry
    • Quotes

Editorials

Navigating ethical dilemmas in genetic testing for Huntington’s Disease

September 6, 2023

Rana Anwar, M.D., Steven Lippmann, M.D.

Introduction: Genetic testing for Huntington’s Disease (HD) offers a precise diagnosis but raises many questions. These include privacy concerns to complex family dynamics; the impact of HD testing extends beyond individual choices. There are clinical dilemmas surrounding HD genetic testing that require thoughtful consideration.

Discrimination /Privacy: One of the foremost concerns in HD genetic testing is the fear of genetic information later being used against individuals. This apprehension comes from potential discrimination, like for employment and insurance coverage. A positive HD test result may jeopardize opportunities and security.

Emotional Impact: Receiving a positive HD test result can be troublesome. The ethical query arises – should people have the right to shield themselves from psychological distress by opting not to be tested or can anyone choose to be tested? Balancing a right to know with the right to avoid distress is a complex personal dilemma.

Family Dynamics: HD genetic testing can affect the whole family. The knowledge of one’s status may necessitate decisions about sharing this information with family members, potentially altering social dynamics and prompting ethical quandaries.

Reproductive Choices: For individuals of childbearing age, a positive HD test result introduces decisions about whether to have biological children. With a 50% risk of passing on the mutated gene, issues emerge regarding the right to have children and the responsibilities tied to potential transmission of the disease.

Informed Consent: It is important to ensure that everyone fully grasps the implications of HD genetic testing. It should be made clear as to whether those concerned are making well-informed choices about undergoing the assessment and considering the emotional burden.

Genetic Counseling: Access to genetic counseling must be provided. Discussion should review false positive results and/or a false negative conclusion, along with their significant clinical implications. This raises concerns about healthcare disparities and the support available to the person facing decisions about genetic testing.

Testing Minors: Testing minors for HD is even more complicated. Parents or guardians must make choices that affect a child’s future. Balancing the child’s best interests clinically with parental autonomy is the goal. 

Research / Data Sharing: Ethical questions emerge over the use of genetic data for research. How should an individuals’ genetic information be used in scientific studies, and who should have access to this data? These considerations are central to the responsible handling of genetic information.

Stigmatization: A positive HD test result can bring about stigmatization within our society. This can significantly affect an individual’s self-worth, financial status, and relationships with others.

Conclusion: The dilemmas about HD genetic testing are multifaceted. Addressing these challenges necessitates balancing autonomy, privacy, informed consent, and an understanding of the consequences of the test results. Genetic counseling and clinician support are essential to guide people through these ethical issues given the complexities presented by Huntington’s Disease.

Related Posts

Editorials /

The role of the h-index in academic medicine

Editorials /

A timeless commitment: Reflections on the Hippocratic Oath

Editorials /

Abraham Flexner history: Celebrated medical educator – improved physician training, yet also left a not well-known legacy  

‹ Loneliness: Surgeon General Dr. Murthy’s warning › CSF HVA concentrations in depressed individuals with or without a history of alcoholism and healthy controls

Editorials

  • The role of the h-index in academic medicine
  • A timeless commitment: Reflections on the Hippocratic Oath
  • Abraham Flexner history: Celebrated medical educator – improved physician training, yet also left a not well-known legacy  
  • Suicide medical malpractice: A conceptual perspective

Research Papers

  • COVID-19 mortality in Europe and the ’Iron Curtain’ between East and West
  • Examination of depressive signs and symptoms among 803 University students in seven Universities and Colleges. Hungary, Romania, Serbia.
  • Examination of spirituality and the dimensions of spirituality among 803 students in seven different Universities. Hungary, Romania and Serbia.
  • Examination of depressive signs and symptoms among 932 students in eight different secondary schools in Hungary

Research News

  • Blood alcohol concentration and suicide mortality in Finland
  • Suicide risk in older adults: clinical responsibilities and medico-legal considerations
  • Conceptualizing a combat veteran’s suicide death through the stress-diathesis model
  • No evidence of a causal link between glucagon-like peptide-1 receptor agonists and suicidal behavior

Latest News

  • FDA launches real-time clinical trial initiative
  • The 2025 ScholarGPS rankings of leading scholars in suicidology
  • Mental health support for healthcare professionals
  • The 2024 ScholarGPS ranking of scholars in the field of suicidology

Interviews with eminent psychiatrists

  • 2026 Interview with Professor Zoltan Rihmer
  • 2026 Interview with Doctor María Dolores Braquehais Conesa
  • 2026 Interview with Professor Shih-Ku Lin
  • Interview with Professor Jess G. Fiedorowicz

Ten Years Ago

  • Suicide malpractice
  • Testosterone levels and future suicide attempts in women with bipolar disorder
  • Bipolar disorder, testosterone administration, and homicide
  • The cosyntropin stimulation test in military veterans with or without posttraumatic stress disorder

Back to Top

  • About
  • Contact
  • Privacy Policy
  • Terms and Conditions
Copyright © 2025 AVCalc LLC. All rights reserved worldwide.